ReBuilder
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ReBuilder, covering 2017-07-12 to 2017-07-12. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer